Clinical Trial Update: Safety and Efficacy Study of GCS-100LE in the Treatment of Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating GCS-100LE for multiple myeloma has been terminated; the report covers safety and potential efficacy findings from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• GCS-100LE (GCS-100LE)

Snippet

Sponsor: La Jolla Pharmaceutical Company | Conditions: Multiple Myeloma | Phase 1 | Status: TERMINATED